Fundamental Data for NVO

NOVO-NORDI(NYSE:NVO)

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world''s largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

# Employees: 0

Address: Novo All?? 2880,Bagsvaerd,,DNK

Phone: 45 44 44 88 88

Fax: 45 4444 6626

Website: www.novonordisk.com

Email: hrmm@novonordisk.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Lars Rebien S??rensen (Presi.; C.E.O.)

Jesper Brandgaard (Exec. V.P.; C.F.O.)

Dividend

Ex-Dividend Date: 1/1/1990

Annual Dividend: $0.78

Current Dividend Yield: $1.18

Dividend Paid (3 months): $0.00

Indicated Dividend: N/A

Earnings

Last Earnings Date: 12/31/2008

Next Earnings Date(Expected): 10/29/2009

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): $3.45

Mean Estimate(Long Term): $19.48

P/E Ratio(Based on EPS estimate): 19.170

Number of Estimates: 5

Shares Performance

Period	NVO	Compare to S&P
YTD	28.72 %	6.53 %
4 Weeks	2.69 %	1.58 %
12 Weeks	8.34 %	2.14 %

Shares Information

Analyst Coverage: Y

Avg Volume: 146837

Shares Outstanding: 592M

Market Cap: $39.22B

52 Week High: $66.58

52 Week Low: $41.97

P/E Ratio: -0.010

PEG Ratio: 0.980

Split: On 12/17/2007 NVO split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -0.01 %

EPS Growth in Last Year: 69.81 %

Sales Growth in Last Quarter: 1.01 %

Sales Growth in Last Quarter: 5.79 %

Financials

Qtr Book Value: $5.86

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 4.260